Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ Cancer
Clinical trial NCT03817411 · UNKNOWN
Trial details
- NCT number
- NCT03817411
- Sponsor
- Taizhou EOC Pharma Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-25
- Primary completion
- 2020-03-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.